Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -37.70%122.5M | ---- | -38.10%196.64M | ---- | 101.14%317.66M | ---- | 96.81%157.93M | ---- | -94.91%80.24M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 83.22%-1.08M | ---- | -318.95%-6.46M | ---- | 21.70%-1.54M | ---- | -207.98%-1.97M | ---- | 71.76%-639K |
| Interest expense - adjustment | ---- | -30.16%38.43M | ---- | 42.58%55.02M | ---- | 51.48%38.59M | ---- | 42.11%25.48M | ---- | 35.68%17.93M |
| Attributable subsidiary (profit) loss | ---- | -93.39%-282.57M | ---- | 25.90%-146.11M | ---- | 6.29%-197.18M | ---- | -8,367.44%-210.42M | ---- | -113.78%-2.49M |
| Impairment and provisions: | ---- | -68.04%78.68M | ---- | 526.49%246.16M | ---- | 7.53%39.29M | ---- | 5,611.61%36.54M | ---- | -101.76%-663K |
| -Impairmen of inventory (reversal) | ---- | 118.55%1.39M | ---- | 515.69%636K | ---- | ---153K | ---- | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | -63.31%77.29M | ---- | 486.11%210.68M | ---- | -1.63%35.95M | ---- | --36.54M | ---- | ---- |
| -Impairment of goodwill | ---- | ---- | ---- | --34.85M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | --3.5M | ---- | ---- | ---- | ---663K |
| Revaluation surplus: | ---- | --110K | ---- | ---- | ---- | -119.47%-248K | ---- | 158.98%1.27M | ---- | -53,900.00%-2.16M |
| -Other fair value changes | ---- | --110K | ---- | ---- | ---- | -119.47%-248K | ---- | 158.98%1.27M | ---- | -53,900.00%-2.16M |
| Asset sale loss (gain): | ---- | 99.95%-160K | ---- | -46.34%-319.86M | ---- | -4,206.16%-218.57M | ---- | 108.11%5.32M | ---- | 95.13%-65.67M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | -41.75%-312.18M | ---- | -4,237.42%-220.24M | ---- | 108.11%5.32M | ---- | 95.13%-65.67M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 97.92%-160K | ---- | -561.48%-7.68M | ---- | --1.66M | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | 9.37%42.91M | ---- | 42.97%39.24M | ---- | 87.20%27.44M | ---- | 26.78%14.66M | ---- | -57.98%11.56M |
| -Depreciation | ---- | 9.37%42.91M | ---- | 42.97%39.24M | ---- | 87.20%27.44M | ---- | 26.78%14.66M | ---- | -57.98%11.56M |
| Exchange Loss (gain) | ---- | 95.79%-49K | ---- | 69.22%-1.16M | ---- | -380.56%-3.78M | ---- | -406.23%-787K | ---- | 1,217.39%257K |
| Special items | ---- | ---- | ---- | -775.21%-7.19M | ---- | 193.18%1.07M | ---- | -225.33%-1.14M | ---- | -82.60%912K |
| Operating profit before the change of operating capital | ---- | -102.19%-1.23M | ---- | 1,966.43%56.27M | ---- | -89.87%2.72M | ---- | -31.55%26.89M | ---- | -87.99%39.28M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -106.11%-255K | ---- | -12.57%4.18M | ---- | 1,914.77%4.78M | ---- | -82.74%237K | ---- | 101.85%1.37M |
| Accounts receivable (increase)decrease | ---- | 79.43%-11.85M | ---- | -1,324.66%-57.61M | ---- | -87.24%4.7M | ---- | 129.05%36.87M | ---- | 64.78%-126.91M |
| Accounts payable increase (decrease) | ---- | 314.72%67.47M | ---- | -307.90%-31.42M | ---- | -10.50%15.11M | ---- | 800.16%16.89M | ---- | 104.82%1.88M |
| prepayments (increase)decrease | ---- | 222.78%118.61M | ---- | -389.52%-96.6M | ---- | 252.09%33.37M | ---- | -219.54%-21.94M | ---- | 131.82%18.35M |
| Special items for working capital changes | ---- | 160.06%218K | ---- | -151.71%-363K | ---- | 2,293.75%702K | ---- | -540.00%-32K | ---- | 99.99%-5K |
| Cash from business operations | ---- | 237.76%172.96M | ---- | -304.53%-125.55M | ---- | 4.18%61.38M | ---- | 189.22%58.92M | ---- | 75.74%-66.03M |
| Other taxs | ---- | -51.01%-13.41M | ---- | -19.08%-8.88M | ---- | 9.91%-7.46M | ---- | 71.71%-8.28M | ---- | 52.14%-29.28M |
| Special items of business | -165.00%-100.77M | ---- | 263.81%155.03M | ---- | -195.33%-94.64M | ---- | 2,640.81%99.27M | ---- | 103.00%3.62M | ---- |
| Net cash from operations | -165.00%-100.77M | 218.68%159.54M | 263.81%155.03M | -349.30%-134.43M | -195.33%-94.64M | 6.49%53.92M | 2,640.81%99.27M | 153.13%50.64M | 103.00%3.62M | 71.41%-95.31M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -83.22%1.08M | ---- | 318.95%6.46M | ---- | -21.70%1.54M | ---- | 207.98%1.97M | ---- | -71.76%639K |
| Dividend received - investment | ---- | -35.03%61.42M | ---- | 83.92%94.52M | ---- | 24.65%51.39M | ---- | 53.52%41.23M | ---- | 106.13%26.86M |
| Decrease in deposits (increase) | ---- | 1,444.00%1.34M | ---- | 58.68%-100K | ---- | -102.16%-242K | ---- | 201.80%11.2M | ---- | -319.08%-11M |
| Sale of fixed assets | ---- | -93.64%573K | ---- | -67.59%9.02M | ---- | 11,687.29%27.82M | ---- | 3,271.43%236K | ---- | --7K |
| Purchase of fixed assets | ---- | 21.19%-23.35M | ---- | -35.16%-29.62M | ---- | 46.61%-21.92M | ---- | 71.68%-41.05M | ---- | -139.14%-144.94M |
| Purchase of intangible assets | ---- | 98.53%-436K | ---- | ---29.57M | ---- | ---- | ---- | -130.46%-696K | ---- | 53.96%-302K |
| Sale of subsidiaries | ---- | ---- | ---- | --220.37M | ---- | ---- | ---- | ---- | ---- | --30M |
| Acquisition of subsidiaries | ---- | -696.61%-143.39M | ---- | 78.36%-18M | ---- | -12,086.46%-83.19M | ---- | --694K | ---- | ---- |
| Recovery of cash from investments | ---- | ---- | ---- | 1,270.72%68.71M | ---- | --5.01M | ---- | ---- | ---- | ---- |
| Cash on investment | ---- | -78.03%-128.21M | ---- | 33.85%-72.02M | ---- | 57.77%-108.86M | ---- | -4,189.65%-257.81M | ---- | ---6.01M |
| Other items in the investment business | 228.36%243.38M | -105.49%-1.27M | -166.26%-189.61M | 1,669.82%23.09M | 834.92%286.16M | -117.93%-1.47M | 47.37%-38.94M | 127.29%8.21M | -1,270.94%-73.98M | -9.89%3.61M |
| Net cash from investment operations | 228.36%243.38M | -185.11%-232.24M | -166.26%-189.61M | 310.04%272.86M | 834.92%286.16M | 44.96%-129.91M | 47.37%-38.94M | -133.36%-236.03M | -1,270.94%-73.98M | 79.29%-101.14M |
| Net cash before financing | 512.39%142.61M | -152.52%-72.69M | -118.06%-34.58M | 282.17%138.43M | 217.42%191.52M | 59.01%-75.99M | 185.76%60.34M | 5.63%-185.39M | 44.22%-70.35M | 76.09%-196.45M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | 15.72%1B | ---- | 3.77%864.92M | ---- | 268.76%833.47M | ---- | 6.32%226.02M | ---- | -58.86%212.58M |
| Refund | ---- | 4.39%-886.88M | ---- | -56.72%-927.57M | ---- | -631.59%-591.85M | ---- | -161.47%-80.9M | ---- | 85.31%-30.94M |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --56.87M | ---- | ---- |
| Interest paid - financing | ---- | 23.67%-43.49M | ---- | -19.54%-56.98M | ---- | -53.08%-47.66M | ---- | -124.56%-31.14M | ---- | -54.30%-13.87M |
| Dividends paid - financing | ---- | 86.34%-9.64M | ---- | ---70.52M | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items of the financing business | -299.50%-107.98M | ---- | 217.23%54.13M | -195.53%-9.5M | -33.93%-46.17M | 1,070.24%9.95M | -132.57%-34.48M | 29.21%-1.03M | -1.01%105.86M | -170.36%-1.45M |
| Adjustment item of financing business | ---- | ---- | ---- | --5M | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from financing operations | -299.50%-107.98M | 127.95%58.97M | 217.23%54.13M | -204.12%-210.98M | -33.93%-46.17M | 20.98%202.64M | -132.57%-34.48M | 5.10%167.49M | -1.01%105.86M | -45.59%159.36M |
| Effect of rate | 570.69%778K | 257.91%4.86M | 104.28%116K | 22.76%1.36M | -1.69%-2.71M | 688.83%1.11M | -1,249.14%-2.67M | 86.50%-188K | -80.71%232K | -252.24%-1.39M |
| Net Cash | 77.17%34.63M | 81.08%-13.72M | -86.55%19.55M | -157.29%-72.56M | 462.07%145.35M | 807.58%126.65M | -27.18%25.86M | 51.75%-17.9M | 285.20%35.51M | 92.99%-37.1M |
| Begining period cash | -5.66%147.63M | -31.27%156.49M | -31.27%156.49M | 127.84%227.69M | 127.84%227.69M | -15.33%99.93M | -15.33%99.93M | -24.59%118.02M | -24.59%118.02M | -77.13%156.51M |
| Cash at the end | 3.91%183.04M | -5.66%147.63M | -52.43%176.16M | -31.27%156.49M | 200.77%370.33M | 127.84%227.69M | -19.92%123.13M | -15.33%99.93M | 10.99%153.76M | -24.59%118.02M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.